Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
5-HT2A Receptor Binding Inhibition Assay from US Patent US20240083872: "CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY"
Assay data:126 Active, 12 Activity ≤ 1 nM, 118 Activity ≤ 1 µM, 126 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Radioligand Binding Assay from US Patent US20240051978: "3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS"
Assay data:4 Active, 3 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Determination of the Effect of a SERCA Agonist on the Reduction of SSR Stress from US Patent US11890279: "Quinolines that modulate SERCA and their use for treating disease"
Assay data:11 Tested
SummaryRelated BioAssays by DepositorRelated BioAssays by Target
Determination of the Effect of a SERCA Agonist on the Reduction of CSR Stress from US Patent US11890279: "Quinolines that modulate SERCA and their use for treating disease"
Assay data:8 Tested
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Serotonin (5-Hydroxytryptamine) 5-HT2A Eurofins Panlabs panel
5HT2AH_AGON Eurofins SafetyScreen44 (BI)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on